We are a clinical-stage global biopharmaceutical company developing a pipeline of novel precision therapies for people with cancer.
Recent News
December 18, 2023
We are a clinical-stage global biopharmaceutical company developing a pipeline of novel precision therapies for people with cancer.
December 18, 2023